TEL AVIV (Reuters) – Teva Pharmaceutical Industries will cut its workforce by more than a quarter, give up many of its manufacturing plants and suspend its dividend on ordinary shares in a much-anticipated overhaul to help pay back its massive debt.
Powered by WPeMatico